DOCSLIB.ORG

Final Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Final Report Research Report Measures and Methodology for International Comparisons of Health Care System Performance Final Report Laurie T. Martin, Carl Berdahl, Rachel M. Burns, Emily Hoch, Evan D. Peet, Peter S. Hussey C O R P O R A T I O N For more information on this publication, visit www.rand.org/t/RRA171-1 Published by the RAND Corporation, Santa Monica, Calif. © Copyright 2021 RAND Corporation R® is a registered trademark. Limited Print and Electronic Distribution Rights This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited. Permission is given to duplicate this document for personal use only, as long as it is unaltered and complete. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial use. For information on reprint and linking permissions, please visit www.rand.org/pubs/permissions. The RAND Corporation is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. RAND is nonprofit, nonpartisan, and committed to the public interest. RAND’s publications do not necessarily reflect the opinions of its research clients and sponsors. www.rand.org Preface Compared with other Organisation for Economic Co-operation and Development (OECD) member countries, the United States ranks lower on several notable health-related outcomes, such as infant mortality, that tend to be overemphasized by stakeholders and used as a marker of health care system performance. However, the driving factors contributing to many of these rankings could be attributed to factors outside of the health care system, such as greater inequality, less social protection, population density, and societal preferences. Concerns have also been raised around the variability in data availability and quality within the United States and abroad, which can introduce bias or make international comparisons more difficult. Given the increasingly important question of what the United States is buying for its health expenditures and interest in understanding what factors of the health system contribute to better health outcomes, in 2020, the Immediate Office of the Secretary of the U.S. Department of Health and Human Services (HHS) sought to identify measures that could improve the ability of the United States and other countries to learn from international comparisons of health system performance specifically. To inform the identification of measures for international comparison that could eventually be proposed to OECD, RAND Corporation researchers worked with a diverse group of 15 experts in quality measurement, clinical care, and health economics to generate and prioritize potential measure constructs that align with HHS priorities and are particularly promising for international comparisons. With few exceptions, the measure constructs identified as most promising will require additional development work to establish their operational definitions and specifications to ensure that any measure developed is valid and feasible for international comparisons of health system performance. This report is designed to lay a strong foundation for these future refinements by noting the degree of consensus among experts about the importance, scientific acceptability, feasibility, and usability of measure constructs; summarizing the strengths and limitations of the measure constructs; and providing additional context that can be useful for informing the selection of measure constructs that might ultimately be developed into measures and proposed to OECD for consideration. This research was funded by the Office of the Assistant Secretary for Planning and Evaluation, HHS (Contract No. HHSP233201500038I), and carried out within the Payment, Cost, and Coverage Program in RAND Health Care. RAND Health Care, a division of the RAND Corporation, promotes healthier societies by improving health care systems in the United States and other countries. We do this by providing health care decisionmakers, practitioners, and consumers with actionable, rigorous, objective evidence to support their most complex decisions. For more information, see www.rand.org/health-care, or contact iii RAND Health Care Communications 1776 Main Street P.O. Box 2138 Santa Monica, CA 90407-2138 (310) 393-0411, ext. 7775 [email protected] iv Abstract In 2020, the Immediate Office of the Secretary of the U.S. Department of Health and Human Services (HHS) sought to identify measures that could improve the ability of the United States and other countries to learn from international comparisons of health system performance. To inform the identification of measures for international comparison that could eventually be proposed to the Organisation for Economic Co-operation and Development (OECD), RAND Corporation researchers worked with a diverse group of 15 experts in quality measurement, clinical care, and health economics to generate and prioritize potential measure constructs that align with HHS priorities and are particularly promising for international comparisons. The authors implemented a modified Delphi panel approach using RAND’s ExpertLens platform. This process occurred in three phases. Phase 1 involved the identification of measure constructs that should be considered for inclusion in the expert rating process. Phase 2 was the initial assessment of each measure construct by experts against prespecified rating criteria. Phase 3 was a virtual convening of experts to discuss the ratings, explore areas of disagreement, and allow experts to adjust ratings, if desired. Eight measure constructs were identified as having the most promise for international comparison, but they will require additional development work to establish their operational definitions and specifications to ensure that any measure developed is valid and feasible for international comparisons of health system performance. This report is designed to lay a strong foundation for these future refinements by noting the degree of consensus among experts about the importance, scientific acceptability, perceived feasibility, and usability of measure constructs; summarizing the strengths and limitations of the measure constructs; and providing additional context that can be useful for informing the selection of measure constructs that might ultimately be developed into measures and proposed to OECD for consideration. v Contents Preface ........................................................................................................................................... iii Abstract ............................................................................................................................................ v Figures ............................................................................................................................................. x Tables ............................................................................................................................................. xi Summary ...................................................................................................................................... xiii Acknowledgments ........................................................................................................................ xix Abbreviations ................................................................................................................................ xx 1. Introduction ................................................................................................................................. 1 Methods ..................................................................................................................................................... 2 Phase 1: Identification of Measure Constructs That Should Be Considered ........................................ 2 Phase 2: Evaluation of Each Measure Construct Against Prespecified Criteria ................................... 3 Phase 3: Convene, Discuss, and Adjust Ratings ................................................................................... 4 Organization of This Report ...................................................................................................................... 6 2. Measure Constructs That Hold the Most Promise for International Comparisons ..................... 7 Treatment and Control of Hypertension ................................................................................................... 7 Description Provided in Evidence Table .............................................................................................. 7 Strengths and Limitations ..................................................................................................................... 8 What Is Needed to Move This Measure Forward ................................................................................. 9 Access to and Coverage for Telehealth ..................................................................................................... 9 Description Provided in Evidence Table .............................................................................................. 9 Strengths and Limitations ..................................................................................................................... 9
Load more

Recommended publications
  • Too Much Medicine?
    Faculty of Health Sciences – Department of Clinical Medicine Too much medicine? A study investigating unwarranted regional variation and use of medical care Ingvild Mathiesen Rosenlund A dissertation for the degree of Philosophiae Doctor – March 2019 TABLE OF CONTENTS ACKNOWLEDGEMENTS ..................................................................................................................... 3 ABBREVIATIONS ................................................................................................................................. 5 LIST OF PAPERS ................................................................................................................................... 6 SUMMARY ............................................................................................................................................. 7 1. PREFACE ............................................................................................................................................ 8 2. INTRODUCTION ............................................................................................................................... 9 2.1 Too muCh mEdiCinE ................................................................................................................ 9 2.2 ExtEnt of ovErusE .................................................................................................................... 9 2.3 MeasurEment of ovErusE .....................................................................................................
    [Show full text]
  • “Reducing Health Care Costs: Promoting Administrative Simplification and Efficiency”
    “Reducing Health Care Costs: Promoting Administrative Simplification and Efficiency” by Matt Eyles President and CEO America’s Health Insurance Plans for the Senate Committee on Health, Education, Labor, and Pensions July 31, 2018 Chairman Alexander, Ranking Member Murray, and members of the committee, I am Matt Eyles, President and CEO of America’s Health Insurance Plans (AHIP). AHIP is the national association whose members provide coverage for health care and related services to millions of Americans every day. Through these offerings, we improve and protect the health and financial security of consumers, families, businesses, communities, and the nation. We are committed to market-based solutions and public-private partnerships that improve affordability, value, access, and well-being for consumers. We appreciate this opportunity to testify on our industry’s leadership in simplifying health care and in efforts to protect patients; support doctors and hospitals in delivering high quality, evidence-based care; and reduce administrative costs. Our members are strongly committed to working with clinicians and hospitals to reduce complexity, improve value and patient health, and increase patient satisfaction. Americans deserve affordable coverage choices that help to improve their health and financial security. To advance this goal, health insurance providers invest in a wide range of initiatives— some of which involve administrative spending—to improve patient care, enhance health outcomes, and protect patients from receiving inappropriate or unnecessary health care services and treatments that provide little to no value. Health insurance providers don’t just pay medical bills—we’re partners, dedicated to better health and well-being for consumers. We believe all patients should be treated with safe, effective care.
    [Show full text]
  • Screening for Social Needs: Guiding Care Teams to Engage Patients
    Screening for Social Needs: Guiding Care Teams to Engage Patients ©2019 American Hospital Association | www.aha.org 1 Screening for Social Needs: Guiding Care Teams to Engage Patients Table of Contents Foreword .......................................................................................................................... 3 Background ....................................................................................................................... 4 Challenges in Screening for Social Needs ........................................................................ 4 Guiding Principles for Screening ....................................................................................... 6 Implementing Social Needs Screening ............................................................................. 7 Patient-centered Conversations about Social Needs ........................................................ 9 Referral Process for Positive Screens ............................................................................. 10 Tailoring Screenings ......................................................................................................... 11 Strategies to Scale Screenings ........................................................................................ 11 Conclusion ...................................................................................................................... 13 References ....................................................................................................................
    [Show full text]
  • Guide for Training Health Workers in Health Care Waste Management
    Guide for Training Health Workers in Health Care Waste Management Citation Guide for Training Health Workers in Health Care Waste Management Ministry of Health Government of Kenya, April 2015 For Enquiries and Feedback, direct correspondence to: The Principal Secretary Ministry of Health Afya House, P.O. Box 30016- 00100 Nairobi Kenya Tel: +254 - 020- 2717077, Ext 45034 Email: [email protected] Website: www.health.go.ke Guide for Training Managers and Health Care Workers iv April 2015 Table of Contents Foreword………………………………………………………………………………………. i Preface……………………………………………………………………………………….. ii Acknowledgement…………………………………………………………………………… iii Citation………………………………………………………………………………………. iv Acronyms…………………………………………………………………………………….. vii Introduction for Trainers…………………………………………………………………….. 2 Module 1: Guide for Training Health Facility Managers and Health Care Workers……….. 12 1.1 Training Overview…………………………………………………………………….. 13 1.2 Introduction to Health Care Waste Management……………………………………… 14 1.3 Waste Minimization…………………………………………………………………… 20 1.4 Segregation of Waste………………………………………………………………….. 24 1.5 Health Worker Safety………………………………………………………………….. 29 1.6 Overview of Health Care Waste Treatment and disposal……………………………… 40 1.7 Roles and Responsibilities in Health Care Waste Management……………………… 44 1.8 Overview of Legal and Policy Framework...………………………………………….. 49 1.9 Developing and Implementing a Facility Health Care Waste Management Plan……... 53 1.10 Key Messages on Health Care Waste Management, Giving Safe Injections, and Reducing Unnecessary
    [Show full text]
  • First, Do No Harm: Calculating Health Care Waste in Washington State
    First, Do No Harm Calculating Health Care Waste in Washington State December 2018 Acknowledgements This report has been prepared by the Washington Health Alliance and is associated with the Choosing Wisely® initiative in Washington state, an effort co-sponsored by the Washington Health Alliance, the Washington State Medical Association and the Washington State Hospital Association since 2015. The organizations currently represented on the Washington State Choosing Wisely Task Force are listed in Appendix D. For more information about this report or the Washington Health Alliance: Contact: Susie Dade at the Washington Health Alliance [email protected] or Nancy Giunto [email protected] We would like to acknowledge that much of the language used in this report to describe specific measures in the Health Waste Calculator is sourced from the “MedInsight Health Waste Calculator Clinical Guides” (Rev: February 2018). We appreciate the detail and thoughtful consideration offered by this resource and are grateful that the Alliance was able to incorporate it into this report. For more information about the Milliman Health Waste Calculator TM : Contact: Marcos Dachary at Milliman: [email protected] Disclaimer: The results included in this report were generated using the Milliman MedInsight Health Waste Calculator (Calculator) and the All Payer Claims Database of the Washington Health Alliance. The Washington Health Alliance and Milliman make no warranties with regard to the accuracy of the Calculator Intellectual Property or the results generated through the use of the Calculator and Alliance data. Neither Milliman nor the Alliance will be held liable for any damages of any kind resulting in any way from the use of results included in this report.
    [Show full text]
  • Using the Health Care Environment to Prevent and Control Infection
    Using the Health Care Physical Environment to Prevent and Control Infection A Best Practice Guide to Help Health Care Organizations Create Safe, Healing Environments A PROJECT BY: The Health Research & Educational Trust of the American Hospital Association American Society for Health Care Engineering Association for Professionals in Infection Control and Epidemiology Society of Hospital Medicine University of Michigan ACKNOWLEDGMENTS This publication was prepared for the Centers for Disease Control and Prevention as part of Contract Number 200 – 2015 – 88275. The project was conducted by the following organizations: • The Health Research & Educational Trust of the American Hospital Association • American Society for Health Care Engineering (ASHE), a professional membership group of the American Hospital Association • Association for Professionals in Infection Control and Epidemiology • Society of Hospital Medicine • University of Michigan As the lead developer for this document, ASHE would like to recognize the expertise and contributions of the following: • Project leader Linda Dickey, RN, MPH, CIC, FAPIC, Senior Director of Quality, Patient Safety & Infection Prevention, University of California Irvine Health • Ellen Taylor, PhD, AIA, MBA, EDAC, Vice President of Research, The Center for Health Design • Laurie Conway, RN, PhD, CIC, Infection Prevention and Control Nurse; Kingston, Frontenac, Lennox, & Addington Public Health • Frank Myers, MA, CIC, Infection Preventionist, University of California-San Diego • Dan Bennett, CHESP, T-CHEST,
    [Show full text]
  • Right Intervention, Right Time: Managing Medically Complex Members Expert Presenters
    Right Intervention, Right Time: Managing Medically Complex Members Expert presenters Dr. Gary Dana, Medical Director, CarePlus, Optum Dr. Scott Howell, MD, Sr. National Medical Director, Optum edical labeling tends to oversimplify patient resulting in chronic kidney disease, and a history of colon cancer that health status, particularly in the case must be monitored. John lives alone, takes 13 medications, utilizes of medically complex members. The 12 providers, and will have 30 to 40 outpatient visits next year. disproportionate impact of the high-risk, Multiple hospital admissions and readmissions also are likely. high-cost population underscores the M John is part of a small portion of the total insured population — importance of using strategic, specialized typically 5 to 10 percent — who account for 30 to 50 percent care management to control the unsustainable costs attached to of a health plan’s medical costs1. He represents the segment of treating chronic diseases — and their debilitating impact on high-risk and highly complex members whose predictable future quality of life. care costs justify implementing provider-led in-home care to As an example, congestive heart failure is the major disease category improve outcomes, enhance quality of life and contain for “John” in Figure 1. His medical record, however, also indicates medical costs. atrial fibrillation, cardiac ischemia, implanted devices, diabetes Figure 1 Medical information for a high-risk and highly complex member John, 83-Year-Old Male • Congestive heart failure • No active complaints COPD Urinary Tract Palliative • Avoid ER visits, inpatient admissions. Heart Failure • When questioned, admits to worsening cough Exacerbation Infection Care/Hospice • Reduce medications, unnecessary procedures.
    [Show full text]
  • Financial Implications of Promoting Excellence in End-Of-Life Care
    Financial Implications of Promoting Excellence in End-of-Life Care PROMOTING EXCELLENCE IN END–OF–LIFE CARE A NATIONAL PROGRAM OFFICE OF THE ROBERT WOOD JOHNSON FOUNDATION Completing the Picture of Excellence In 1997, The Robert Wood Johnson Foundation launched a national program Promoting Excellence in End-of-Life Care with a mission of improving care and quality of life for dying Americans and their families. We soon realized that the metaphor of a jigsaw puzzle seemed apt in describing our efforts to expand access to services and improve quality of care in a wide range of settings and with diverse populations. No single approach would suffice—a variety of strategies, models of care, and stakeholders are necessary to successfully complete the picture. This monograph represents one aspect of our work and one piece of the puzzle of ensuring that the highest quality of care, including palliative care, is available to all seriously ill patients and their families. Acknowledgements This publication was produced by Promoting Excellence in End-of-Life Care, a National Program Office of The Robert Wood Johnson Foundation, directed by Ira Byock, MD. Primary authors of this report are: Larry Beresford Ira Byock, MD, Director Jeanne Sheils Twohig, MPA, Deputy Director The authors thank Yvonne J. Corbeil for editorial assistance. We extend special appreciation to the individuals and colleagues in the projects mentioned who gave their time to provide infor- mation for this report. About the Artist Deidre Scherer’s fabric and thread images on aging have appeared in over one hundred individ- ual and group shows throughout the United States and internationally, including her solo exhibi- tion at The Baltimore Museum of Art.
    [Show full text]
  • Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence (MUSTCOOL)
    Page 1 of 39 Cover letter for Protocol Official title: Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence (MUSTCOOL) NCT02626156 Document date: 07/23/2018 Version 10.0 07/23/18 Page 2 of 39 Medical University of South Carolina Protocol PI Name: Teresa J. Kelechi, FAAN, RN, PhD. Study Title: Monitoring and managing newly healed chronic leg and foot ulcer skin temperature: a cooling intervention (MUSTCOOL) to prevent ulcer recurrence TABLE OF CONTENTS PAGE A. SPECIFIC AIMS 2. B. BACKGROUND AND SIGNIFICANCE 3. C. PRELIMINARY STUDIES 3. D. RESEARCH AND DESIGN METHODS 6. E. PROTECTION OF HUMAN SUBJECTS 16. E.1. RISKS TO SUBJECTS 16. E.1.a. Human Subject Involvement and Characteristics 17. E.1.b. Source of Materials 18. E.1.c. Potential Risks 18. E.2. ADEQUACY OF PROTECTIONS AGAINST RISKS 19. E.2.a Recruitment and Informed Consent 19. E.2.b Protection against Risk 20. E.3. POTENTIAL BENEFITS OF THE PROPOSED RESEARCH 20. E.4. IMPORTANCE OF THE KNOWLEDGE TO BE GAINED 21. E.5. SUBJECT SAFETY AND MINIMIZING RISKS 21. F. REFERENCES/LITERATURE CITATIONS 28. G. CONSULTANTS 33. H. FACILITES AVAILABLE 33. I. INVESTIGATOR BROCHURE 36. J. APPENDIX 36. Version 10.0 07/23/18 Page 3 of 39 A. SPECIFIC AIMS Purpose: Elevated skin temperature after closure of a chronic ulcer is predictive of ulcer recurrence due to aberrant and persistent inflammation resulting in tissue destruction 1-3. The proposed randomized controlled trial (RCT) will test a patient-directed self-monitoring/self-management intervention (MUSTCOOL) with respect to its ability to prevent recurrence of chronic venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs) while improving symptoms, physical activity, and quality of life.
    [Show full text]
  • Breaking the Fever: a New Construct for Regulating Overtreatment
    Breaking the Fever: A New Construct for Regulating Overtreatment Isaac D. Buck* The Department of Justice’s (“DOJ”) current theory of overtreatment regulation — and, in fact, all of the prominent amount of medical necessity-based health care fraud enforcement — adopts the argument that providers are violating the False Claims Act when they submit bills to the federal government for care they administered that is not medically necessary. Besides stoking the ire of the provider community, this regulatory strategy is susceptible to inefficiency, imprecision, and — as I have argued before — overuse. Whether a procedure was medically necessary can be a highly difficult question to answer, one easily swayed by clinically-complex details, and one made murkier by clinical and geographic variation, Medicare’s often outdated and/or inaccurate coverage determinations, and overtreatment’s settlement-based regulatory regime that features few trials. This strategy can stifle innovation and arrest the natural evolution of the standard of care. Given these difficulties, and aware of the imminent cost challenges facing the Medicare program, this Article presents a proposal that seeks to improve the efficiency and intellectual honesty of overtreatment regulation by advocating for an explicit shift in the focus of enforcement from medical necessity to excess utilization. Instead of targeting providers and hospitals for a contravention of Medicare’s medical necessity determination during a * Copyright © 2015 Isaac D. Buck. Assistant Professor, Mercer University School of Law; Juris Doctor, University of Pennsylvania Law School; Master of Bioethics, University of Pennsylvania; Bachelor of Arts, Miami University (Ohio). I owe a debt of gratitude to the participants, readers, and organizers of the 2014 Works-In-Progress and New Scholars Panels at the Southeastern Association of Law Schools annual meeting and at the 2014 University of Kentucky Emerging Ideas Conference, where I presented earlier versions of this paper.
    [Show full text]
  • The Value Initiative Issue Brief 5: Improving Value for Patients with a Serious Illness
    Issue Brief 5 Improving Value for Patients with a Serious Illness This is the fifth in a series of Issues Briefs framing the complex issue of affordability. These briefs can be used to initiate conversations with stakeholders in your community. What is Serious Illness? State of Serious Illness in the U.S. Serious illnesses are complex and chronic health 12 million adults and 400,000 conditions that carry a high risk of mortality children are living with serious and either negatively affect an individual’s daily illness. function or quality of life, or excessively strain 1 their caregiver. It is likely everyone knows a friend, $909 billion per year spent on family member, neighbor or colleague affected by patients with serious illness. a serious illness, such as cancer, congestive heart failure, chronic obstructive pulmonary disease, It is possible to save $3.5 billion kidney failure, Alzheimer’s and other dementias, per year if hospitals nationwide Parkinson’s disease or ALS. Though distinct in their implement quality palliative care. pathologies and treatments, all of these illnesses involve functional impairment, limit patients’ abilities to go about their daily activities, require significant medical and nonmedical support, and put them at high risk of hospitalization. Twelve million U.S. adults and 400,000 children are living with a serious illness2, and that number is expected to grow exponentially over the next 25 years.3 As hospitals and health systems advance health in their communities and improve affordability, there is a pressing need to implement value-based strategies focused on meeting the needs of people with serious illnesses.
    [Show full text]
  • Evidence for Overuse of Medical Services Around the World
    Series Right care 1 Evidence for overuse of medical services around the world Shannon Brownlee, Kalipso Chalkidou, Jenny Doust, Adam G Elshaug, Paul Glasziou, Iona Heath*, Somil Nagpal, Vikas Saini, Divya Srivastava, Kelsey Chalmers, Deborah Korenstein Lancet 2017; 390: 156–68 Overuse, which is defined as the provision of medical services that are more likely to cause harm than good, is a Published Online pervasive problem. Direct measurement of overuse through documentation of delivery of inappropriate services is January 8, 2017 challenging given the difficulty of defining appropriate care for patients with individual preferences and needs; overuse http://dx.doi.org/10.1016/ can also be measured indirectly through examination of unwarranted geographical variations in prevalence of S0140-6736(16)32585-5 procedures and care intensity. Despite the challenges, the high prevalence of overuse is well documented in high-income This is the first in a Series of four papers about right care countries across a wide range of services and is increasingly recognised in low-income countries. Overuse of unneeded See Comment pages 101, 102, services can harm patients physically and psychologically, and can harm health systems by wasting resources and and 105 deflecting investments in both public health and social spending, which is known to contribute to health. Although Lown Institute, Brookline, MA, harms from overuse have not been well quantified and trends have not been well described, overuse is likely to be USA (S Brownlee MSc, increasing worldwide.
    [Show full text]